Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment - Wikidata - thesis-toulmin - TriplyDB

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment

http://www.wikidata.org/entity/Q34973698

about

Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis Disease-toxicant interactions in Parkinson's disease neuropathology Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder.Pleiotrophin regulates microglia-mediated neuroinflammation.Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine.Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.Parkinson's disease managing reversible neurodegeneration.Which medications are suitable for agonist drug maintenance?Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.Structural abnormality of substantia nigra induced by methamphetamine abuse.The neurochemical consequences of methamphetamine self-administration in male and female rats.The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.Behavior of α-synuclein-drug complexes during nanopore analysis with a superimposed AC field.Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.Self-administration of methamphetamine alters gut biomarkers of toxicity.The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.

P2860

Q27305163-9D81DB18-D515-4A30-AC59-9091CAA61A0E Q28384572-D08AA87C-7B1C-4ED2-B924-37916435E708 Q29248297-D0A73685-A822-4E64-9DFB-56CC29301D90 Q33702977-4263EB89-BD9C-4BFB-93A4-77C620EC23D3 Q34504916-2E40EF3B-A7DB-44A8-A746-FB0C3491B108 Q34673305-26FEEBE8-BAC5-4319-8DFB-7A0A96E84650 Q35810975-CF832B3A-761D-477A-BE9D-BB65391872FF Q36316462-9D9343E0-B2A7-4A43-9F3F-93FCA39319DB Q36387048-D7BC1F3C-B3C9-47EB-A14D-626D677A34CC Q36476821-0F590C90-1409-42B4-8BAA-FB3D7475591D Q37316136-73236368-0E6C-4DE1-B3AA-5420799C3201 Q37680127-F34992EF-5A24-4118-9525-6BB3E98C26C3 Q38731675-3FADE8CC-AD2B-4D03-91A2-05D722CD57BE Q38744676-7A450387-2479-4674-A38B-FF38C92EC3B7 Q38838536-D10B604A-3189-44D2-B6C0-CB6035B527CF Q38917424-9C81B89A-09D2-4541-A6DA-57D72E00EAA8 Q38926228-2FE9D6E8-9ADE-4EF7-8240-9DF6E9D9282A Q39043765-56406448-58F3-4920-9EEA-93A8E649ACE4 Q39153958-A75A27D2-CACF-4F2C-8339-03E3CA0FB6E4 Q39356354-CF4D4D4F-D7EE-48BD-B1BC-1984D85E368C Q40030359-F49D25B3-03FD-40D9-9282-77EE91BB3FFC Q40390581-58AC41B6-D235-494E-8C2E-3636B8CE6FC4 Q40983371-A348982A-6CFD-4DD6-9C16-6D52DC3A16C0 Q42220091-59B3EE40-7E37-4298-87B6-194AD8185E8C Q46429572-B150BCDA-867E-420C-B2F1-3DC4176585B8 Q47693643-31BD9E86-F9CF-497C-AE0A-7E0FB935B36D Q47720605-99653934-8859-4707-A052-7FD746F6A74C Q47845016-27A3D79C-C092-4163-B2BD-7B4E53DC2FAD Q48056568-76983900-3B1F-4F8F-B95A-99F58C2B73AD Q48171776-9EB73D56-86F9-437F-8CC5-731523D1E2C8 Q48184416-ACEB9491-C543-4B19-801A-4B4D8A00F7FA Q48302266-42BAB483-F64C-4EA1-B4AD-E5A3EEC46D1D Q51545497-B39FC29A-E930-4FA4-BDA4-3772A8829C8B Q52148359-C37BDACD-9A4C-4D56-9941-910CE741D513 Q52313428-33D0FB13-9853-469D-92E6-881B218969C8 Q55284097-63E72942-8110-4DAB-8433-11C870191048

P2860

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment

http://www.wikidata.org/entity/Q34973698

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Methamphetamine/amphetamine ab ...... a population-based assessment

@ast

Methamphetamine/amphetamine ab ...... a population-based assessment

@en

Methamphetamine/amphetamine ab ...... a population-based assessment

@nl

type

label

Methamphetamine/amphetamine ab ...... a population-based assessment

@ast

Methamphetamine/amphetamine ab ...... a population-based assessment

@en

Methamphetamine/amphetamine ab ...... a population-based assessment

@nl

prefLabel

Methamphetamine/amphetamine ab ...... a population-based assessment

@ast

Methamphetamine/amphetamine ab ...... a population-based assessment

@en

Methamphetamine/amphetamine ab ...... a population-based assessment

@nl

P1433

Q34973698-1B186631-BFC1-425D-BB9F-4FAC9FF38707

P1476

Q34973698-B04486E3-3F5B-4B83-AC00-52310B32695D

P2093

Q34973698-330D614B-C8D4-4687-A041-73128A1EBDDD

Q34973698-50268CE1-5054-4D24-87EA-64291CB86B32

Q34973698-542E121B-7171-4D91-BC57-BAE495CDF2D7

Q34973698-9E03363E-9047-4006-B9E4-4FD0E461751F

Q34973698-BF6EFCD0-7497-4912-87D9-7242FE4B3871

Q34973698-E74FE59D-E8AE-4264-AB53-53A318692ECB

P2860

Q34973698-008CAF55-39ED-4277-9528-1C13D5A54FE3

Q34973698-00C805BC-D655-45B2-85B6-58CB64E8BB5C

Q34973698-018C7E95-ABEB-42A4-BCC4-03DB9C6E37E3

Q34973698-13FF7251-91B8-44D9-8AEC-6035161E8CB2

Q34973698-1DD27B2E-5C99-4BDA-9B26-5EB27DAF9E43

Q34973698-25987F46-81B5-4F9E-9EAD-C0537B7308D8

Q34973698-314F0850-4226-44B9-93C0-F63E244A1EA2

Q34973698-31F145F1-3FBC-44A6-AC72-A1EC40423309

Q34973698-32C00AD9-DDF5-466C-A6C5-CBDDEEFB9E4D

Q34973698-35547077-78F3-409E-84BE-6A4189F2CBD5

P304

Q34973698-9D0093AA-06A5-415D-BF91-034FDEC40E3D

P31

Q34973698-9FC2ECE2-F9EC-44D0-8BD2-48A65BC0CDA2

P356

Q34973698-8829481A-9B49-4257-B765-739F8A638A1A

P478

Q34973698-352F8AAB-31AC-4B38-8968-1F3EE0888B5B

P577

Q34973698-BEAFFE5B-5EB6-4BD4-9753-BE752FFD6427

P5875

Q34973698-4EACDB22-A5A6-4033-B8B7-EA78A4434C0D

P698

Q34973698-83F50E6C-4C78-4F60-BCE9-9C54DB4FDF97

P921

Q34973698-38E7935F-BE37-4589-8356-0A8CEA595993

P932

Q34973698-B45A15C0-0044-44E9-9549-3168A38A5486

P356

J.DRUGALCDEP.2014.10.027

P1433

Drug and Alcohol Dependence

P1476

Methamphetamine/amphetamine ab ...... a population-based assessment

@en

P2093

Annette E Fleckenstein

http://www.w3.org/2001/XMLSchema#string

Glen R Hanson

http://www.w3.org/2001/XMLSchema#string

Karen Curtin

http://www.w3.org/2001/XMLSchema#string

Ken R Smith

http://www.w3.org/2001/XMLSchema#string

Michael J Crookston

http://www.w3.org/2001/XMLSchema#string

Reid J Robison

http://www.w3.org/2001/XMLSchema#string

P2860

Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.

Treatment for amphetamine psychosis.

Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey.

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data.

Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice

Movement disorders and AIDS: a review.

New insights into the mechanism of action of amphetamines.

Substance abuse in women

P304

30-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUGALCDEP.2014.10.027

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269190631

http://www.w3.org/2001/XMLSchema#string

P698

25479916

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4295903

http://www.w3.org/2001/XMLSchema#string